Breast
CME
Laura Dominici, MD
Associate Professor of Surgery, Harvard Medical School
Dana-Farber/Brigham Cancer Center, United States
Disclosure information not submitted.
Sara Tolaney, MD MPH (she/her/hers)
Associate Professor
Dana-Farber Cancer Institute, United States
Disclosure information not submitted.
Adrienne Waks, MD
MD
Harvard Medical School Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Disclosure information not submitted.
To pre-register, please visit: PeerView.com/23EBC-Live
This CME/MOC activity is provided by PVI, PeerView Institute for Medical Education.
This activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc.
Key Reasons to Attend
• Keep current with the latest treatment advances in EBC: Learn how neoadjuvant and adjuvant systemic therapies are changing the standards of care and transforming patient outcomes
• Improve best practices in managing patients with EBC: Receive guidance to optimize multidisciplinary collaboration and make the most of the current and emerging multimodal therapy options for EBC
Dinner will be served.